Company CVAbout Sotac Pharmaceuticals Ltd 
Sotac Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of "M/s Sotac Pharmaceuticals", pursuant to a Deed of Partnership dated October 28, 2015. Thereafter "M/s. Sotac Pharmaceuticals" was converted from Partnership Firm to a Private Limited Company in the name of "Sotac Pharmaceuticals Private Limited" dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 11.05 Cr
Number of Shares
1.1 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
10-Apr-2023
1.1
11.05
3000000
10
Public Issue
10-Apr-2023
1.1
11.05
3000000
10
Public Issue
30-Dec-2022
80.5
8.05
5750000
10
Bonus Issue
20-Mar-2020
23
2.30
1350000
10
Right Issues
30-Sep-2016
9.5
0.95
850000
10
Private Placement
18-Dec-2015
1
0.10
100000
10
Subscriber to MOA
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 4 FIIs (16.14%)
Promoter with highest holding
Kiran Baldevbhai Jotania (13.11%)
Highest Public shareholder
Nav Capital Vcc - Nav Capital Emerging Star Fund (7.09%)
Individual Investors Holdings
5.13%
Board of Directors
Management
Designation
Remuneration
Sharadkumar Dashrathbhai Patel
Chairman & Managing Director
0
Dineshkumar Babulal Gelot
Whole-time Director
0
Vishalkumar Devrajbhai Patel
Executive Director
0
Chetankumar Bachubhai Patel
Executive Director
0
Ms. Nidhiben Patel
Independent Non Exe. Director
0
Hetal Umangbhai Shah
Independent Non Exe. Director
0
Heena Viral Patel
Independent Non Exe. Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
25 Cr
(Quarterly Results - Jun 2024)
Net Profit:
1 Cr
Pharmaceuticals & Biotechnology
INR Cr (Micro Cap)
30.00
NA
0.00%
0.00
0.00%
0.00
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
